The ability to predict defibrillation efficacy at the time of subcutaneous implantable cardioverter-defibrillator implantation without the need to induce ventricular fibrillation might eliminate the need for defibrillation testing. The purpose of this study was to determine the association of high-voltage impedance and system implant position on ventricular fibrillation conversion success with a submaximal 65-J shock.
T
he subcutaneous implantable cardioverter-defibrillator (S-ICD) is an entirely extravascular system with no requirement for intracardiac instrumentation. The S-ICD is a proven alternative to transvenous implantable cardioverter-defibrillator systems. [1] [2] [3] Randomized clinical trials 4, 5 and current society recommendations support implantation of a transvenous implantable cardioverter-defibrillator without conversion testing of ventricular fibrillation (VF); however, implantation of an S-ICD continues to receive a class I recommendation for defibrillation threshold testing. 6 The ability to predict defibrillation efficacy at the time of S-ICD implantation without the need to induce VF may eliminate the need for such testing.
Based on the high success of conversion in the IDE study (Investigational Device Exemption), 2 as well as the EFFORTLESS 3 and Post-Market Approval 7 registries, many operators have implanted the S-ICD without defibrillation threshold testing. [8] [9] [10] Clinical characteristics such as body mass index (BMI) and race have been associated with VF conversion failure. 7, 11, 12 Objective parameters predicting defibrillation success have yet to be characterized to identify patients in whom conversion testing may be deferred.
High-voltage (HV) impedance measures the resistance between the coil and the generator and is, among other variables, dependent on generator-lead distance, the body tissues between these electrodes, and is particularly dependent on adipose tissue. 13 Predictors of impedance, therefore, correlate directly to implant technique and body habitus characteristics. To date, there has not been a systematic evaluation of both system impedance and device position for conversion efficacy in the S-ICD. Accordingly, we sought to analyze implant characteristics within the IDE study to identify implant criteria that may better predict the need for defibrillation thresholds.
METHODS
Because of the sensitive nature of the data collected for this study, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be sent to Boston Scientific at http://www.bostonscientific.com/content/gwc/en-US/data-sharing-requests.html.
The aims of this study were 2-fold. First, to determine whether HV impedance is independently associated with VF conversion success with submaximal 65-J shock. Second, to evaluate the association of HV impedance with system implant position. Further analysis was performed on the direct association of conversion success to key implant positioning parameters and body habitus.
Details of the IDE trial have been reported previously. 2 Briefly, patients with class I or IIa implantable cardioverterdefibrillator indication were enrolled from 2010 to 2011 in 33 centers in 5 countries (28 centers in the United States). The study protocol and consent forms were approved by the local institutional review boards. All patients gave written consent for participation. Of 321 patients undergoing implant procedure, 320 patients underwent VF induction. Chest radiographs were obtained after implantation, and parameters were measured by experienced observers.
Patient Inclusion
Three hundred twenty patients participating in the IDE study were reviewed for this analysis. Per IDE protocol, a successful conversion test required 2 consecutive VF conversions at 65 J in the same shock vector, within a maximum of 4 VF conversion attempts with the use of the same polarity. Patients who completed VF induction with conversion attempted at 65 J and who had HV impedance data and thoracic imaging data were included in the analyses ( Figure 1 ). All VF inductions were categorized as success or failure for conversion testing. Individual thoracic posterior-anterior and lateral imaging was also reviewed according to defined criteria established at the onset of the IDE study. The position of the pulse generator (PG) and coil was assessed as described and illustrated in Figure 2 . The PG was determined to be anterior or posterior from the lateral chest radiograph, and the inferior or superior position was determined by the posterior-anterior chest radiograph. Similarly, the electrode position was evaluated from the posterior-anterior chest radiograph to determine the inferior or superior position and the lateral positioning. In addition, electrode coil depth was assessed via lateral images, based on the distance between the lead and the sternum using the width of the coil (3-mm diameter) as 1 U. Coil depth was measured at the inferior, middle, and superior locations of the electrode, and the average of 3 measurements was calculated. For cases with intraoperative repositioning, only images in the final system position were available. Positional parameters that were univariably associated with a higher impedance were used to define suboptimal system position for analyzing direct association of conversion success. Absence of these suboptimal positional parameters was then defined as appropriate position.
The primary outcome of interest for this analysis was conversion success during induction testing with 65 J S-ICD shock.
Statistical Methods
Descriptive statistics are reported using mean for normally distributed continuous variables, median and interquartile range for non-normally distributed continuous variables, and
WHAT IS KNOWN?
• Subcutaneous implantable cardioverter-defibrillator is associated with high defibrillation success.
• Impedance is inversely related to subcutaneous implantable cardioverter-defibrillator shock success.
WHAT THE STUDY ADDS?
• This article demonstrates that impedance and lead position are important for defibrillation success.
• It shows that a poorly, inferiorly implanted system is associated with high impedance and a decreased probability of success.
frequency and percentage for categorical variables. Wilcoxon signed-rank or t tests were used to perform comparisons between continuous variables, as appropriate, and χ 2 tests, or exact tests where appropriate, were used to perform comparisons between categorical variables. A paired t test was used to compare impedance before and after repositioning for repositioned subjects.
Aim 1: Association of Impedance and VF Conversion
A univariable and multivariable analysis was used to identify characteristics that predicted VF conversion. Outcomes of all 65-J tests in the patient's final implant position were used to define a binomial response variable for each patient, accounting for variable numbers of tests per patient (range, 1-7 tests). Clinically relevant patient variables and HV impedance were tested in a univariable logistic regression model. Variables with P <0.10 in univariable analyses were candidates for the multivariable model. Backward selection with a P ≤0.05 stay criterion was used to determine the final multivariable model.
Aim 2: Association of System Implant Position and HV Impedance
To evaluate which positional variables contribute most to the observed impedance value, univariable linear regression models were constructed for each positional variable with an outcome of HV impedance. Variables with P <0.10 in univariable analyses were candidates for the multivariable model. Backward selection with a P ≤0.05 stay criterion was used to determine the final multivariable model.
All statistical analyses were performed using SAS, version 9.4 (SAS Institute, Cary, NC).
RESULTS
The cohort of 282 patients consisted of 74.1% male patients with a median age of 54.3 (42.2-64.5) years. The indication for implant was primary prevention in 81.1% of patients. The median ejection fraction was 30.0% (25.0%-39.0%), and most patients (67%) had New York Heart Association class II/III heart failure. Median BMI was 28.6 kg/m 2 (25.0-32.8). Patients excluded from the analysis because of missing data (n=39) were younger (P=0.003), had a higher average ejection fraction (P<0.001), and a higher proportion had hypertrophic cardiomyopathy (P<0.001) than patients included.
Defibrillation shock polarity was configured in standard polarity for all tests in 266 patients, reverse polarity for all tests in 1 patient, and 15 patients had tests in both standard and reverse polarity.
Conversions at 65 J were recorded in 637 inductions in 282 patients. Sixty-two conversion failures (9.7%) were recorded in 42 (14.9%) patients. Patients with ≥1 conversion failures were more likely to be men, had a higher mean ejection fraction, and a lower proportion had a history of myocardial infarction (Table 1) .
Shock Impedance and Defibrillation Success
First shock efficacy was the highest for impedances of ≤89Ω ( Figure 3 ). In the first conversion test in the final position, conversion efficacy was 94.7% for impedance <90Ω, 76.7% for impedance ≥90Ω, and 70% >110Ω. The most common range of shocking lead impedances was from 60 to 69Ω, and 193 (68%) of the 282 patients had impedance of 50 to 89Ω.
There was no difference in time to therapy for impedances >90Ω (14.6±3.0 s) or <90Ω (14.4±2.8 s; P=0.515). There was a statistically significant but clinically insignificant change in impedance between the first (76.50±21.14Ω) and the second shock (74.88±20.65Ω; difference, 1.63Ω; P<0.0001).
Univariable and Multivariable Factors Associated With Defibrillation Success
Univariably, lower BMI, body surface area, and shocking impedance were associated with a higher conversion success rate, whereas kidney disease and white race were associated with a lower conversion success rate ( Figure 4A ). In multivariable modeling, kidney disease was no longer significant (P=0.07), whereas other factors remained significant ( Figure 4B ). Body surface area was not included in the multivariable model because of its high interdependence with BMI. . optimal: if the PG is at the fifth or sixth intercostal space; inferior: if the PG is below the sixth intercostal space; superior: if the PG is above the fifth intercostal space. The PG should be at the same level as the xiphoid process. C, Electrode placement parameter 1 (PA chest radiograph view). Optimal: if the sense B/proximal electrode is located in line with the xiphoid process; inferior: if the sense B/proximal electrode is located below the xiphoid process; superior: if the sense B/proximal electrode is located above the xiphoid process. If the patient has sternal wires, most likely, there is no xiphoid process, therefore, sense B should be ≈1 rib space after the last sternal wire. In some cases, if the sense B electrode has pulled back in the direction of the PG, then the lead tip is most likely inferior as a result. (Continued )
System Position and Lead Impedance
Each of the 4 system positions along with electrode coil depth were evaluated against average impedance in univariable modeling. Electrode or PG position being inferior, defined for the electrode as the B electrode inferior to the xiphoid and for the PG as inferior to the sixth intercostal space, was associated with higher impedance, as was coil depth with impedance increasing for each coil depth distance from the sternum (Table I in the Data Supplement). Electrode position inferior along with electrode coil depth remained significant in the multivariable model with inferior position, and each increase in the distance between the subcutaneous coil and the sternum associated with an increase in system impedance ( Figure 5 ). There were 95 subjects with appropriate position (noninferior electrode and PG, coil depth ≤3 mm) and average impedance <90Ω. The first shock success rate in this group was 94.7%.
The electrode and PG were both inferiorly implanted in 17 patients. 
BMI and System Position
Positional variables that were associated with a higher impedance (electrode or PG position being inferior, coil depth >3 mm) were used to define suboptimal system position, whereas appropriate position was defined as the absence of any suboptimal positional variables (electrode and PG noninferior, coil depth ≤3 mm). Of patients with suboptimal position, a similar proportion had BMI >30 versus <30 kg/m 2 ( 
System Repositioning
Impedance data on 18 patients where the electrode (14) or PG (4) was repositioned was available pre-repositioning and post-repositioning ( Figure I in the Data Supplement). After repositioning, there was a significant decrease in impedance of 9.89±14.22Ω. Seven patients had a decrease of >10Ω, 10 patients had a Figure 2 Continued. D, Electrode placement parameter 2 (PA chest radiograph view). Optimal: if the entire electrode (sense A, coil, and sense B) is located in the region over the sternum. In addition, if a portion of the electrode is located in the region over the sternum and then the lead is either curved or angled, it is categorized as optimal, and the curve or angle is documented using electrode parameter 3; right lateral: if the majority of the electrode is to the right of the sternum; left lateral: if the majority of the electrode is slightly to the left of the sternum; grossly left lateral: if the electrode is located grossly to the left of the sternum. E, Electrode coil depth (lateral chest radiograph view). Lines representing the thickness of the electrode are constructed on the image. The superficial distance from the sternum is measured as a multiple of coil width at inferior, middle, and superior locations of the electrode.
change of <10Ω in either direction, and 1 patient had an increase of >10Ω. Twelve of the 18 patients met the implant VF conversion criteria after the repositioning. Patients who passed testing after repositioning had a significant decrease in impedance (Table 3) .
DISCUSSION
This is the first study evaluating both impedance and position for conversion efficacy in the S-ICD. The primary results of this study were that both shock imped- ance and the anatomic position of the system (PG and lead) were associated with defibrillation efficacy. Specifically, an impedance ≥90Ω, an inferior system placement, and superficial coil placement were associated with shock failure.
Previous S-ICD studies demonstrated overall high first shock efficacy >98% at 80 J and 91.2% <80 J. 7 This study demonstrates that the likelihood of defibrillation success in converting VF is inversely related to the system impedance. In a multivariable analysis of VF conversion testing at 65 J, higher impedance, higher BMI, and white race were associated with lower conversion success. With impedances ≤89Ω, conversion efficacy at 65 J was ≈95%. With impedances >90Ω, the conversion efficacy decreased to ≈77%. It may be worth noting that in this analysis of the IDE study, overall first shock conversion efficacy for induced episodes in the final position (89.2%) was lower than that in the PostApproval Study (95.6%). The difference may be due to several factors including patient comorbidities but also improving implant technique over time.
Although impedance is correlated with conversion success, it is unlikely that any impedance threshold will be associated with 100% success or 100% failure. Patients with chronic obstructive pulmonary disease may have a higher impedance, and the S-ICD may still be efficacious. An anterior device placement and leftward deviated coil at the correct tissue depth may shunt current through the chest wall muscle, achieving a low system impedance but low current flow through the heart. A left-sided pleural effusion or hemothorax could reduce impedance but shunt current away from the heart. Therefore, impedance alone should not be a metric by which defibrillation threshold testing is deferred in S-ICD patients.
Our analysis also identifies a system position associated with higher impedance and higher risk of conversion failure: inferior PG and inferior electrode. In addition, we demonstrate that increased subcutaneous fat underneath either the coil or the generator impairs system success, and an increase in shocking impedance is observed. This is consistent with the results from computer modeling data that suggest that implantation technique can alter energy requirements for conversion efficacy and, therefore, conversion success. 13 Figure 5 shows the relationship between the coil electrode distance from the sternum and the resulting impedance. Impedance is a by-product of implantation technique and directly impacts the current for defibrillation. For example, if a 65-J shock with an impedance of 110Ω failed, and repositioning of the electrode reduced the impedance to 90Ω, the defibrillation current would be increased by 22%. To achieve this same 22% increase without repositioning, the electrode would require a 97-J shock, because energy increases as a square of the voltage. The combination of anatomical positioning and resulting system impedance are the strongest predictors of successful conversion. Increasingly anterior positioning of the generator lowers conversion success by shifting the defibrillation vector away from the car- diac structures while having minimal impact on shocking impedance. 13 Failure of conversion with appropriate impedance should also raise the possibility of inappropriate system position.
Of the 18 patients with failed protocol conversion testing, 12 (67%) passed the implant criteria of 2 consecutive conversions at 65 J after repositioning. This may underscore the importance of implant location. It is unlikely that passing 2 consecutive conversion tests would occur by chance; however, it is difficult to know on an individual patient basis the relative effect of regression to the mean versus improved defibrillation efficacy via repositioning.
It has been previously reported that patients with high BMI had significantly lower conversion success. 11 This study shows that patients with high BMI have increased likelihood of inferiorly positioned electrodes and PG and superficially positioned coils, with resulting increased impedances. Yet when appropriate system position was achieved in patients with high BMI, conversion efficacy was not lower and was numerically higher than lower BMI patients with appropriate system position. It is rea- sonable to assume that the likelihood of delivering the system in the subcutaneous fat tissue rather than on the fascial plane is the mechanism. Among patients with higher BMI, dissection to reach deeper planes is complicated by increased bleeding and mechanical obstruction, which may lead to deploying the electrode or the device more superficially in the subcutaneous adipose tissue. Obese patients may be better served with fluoroscopic guidance during the implant procedure. This may permit the electrode to be implanted close to the sternum and the device close to the chest wall. This will improve the defibrillation vector and should prevent the system from being deployed in the subcutaneous fat tissue or over the abdominal cavity, both of which increase HV impedance. Previous studies have demonstrated that fat below the critical components of the system will significantly increase the impedance. 13 The shocking electrode impedance is typically determined during the 65-J VF conversion testing performed at implant but can also be obtained with manual delivery of a 10-J shock. This study demonstrates that after proper system placement, impedance is a strong determinant of VF conversion success. Although the anterior-posterior image on a chest radiograph can be used to confirm appropriate system placement, a remaining challenge during the implant process is obtaining a true lateral fluoroscopic image to determine distance of the electrode from the sternum. Impedance during the procedure may be a good surrogate for electrode coil depth.
The factors affecting defibrillation with other systems have been extensively studied over the years. [14] [15] [16] Although the size of the delivered shock is traditionally measured in energy (eg, joules), studies of transcutaneous and transvenous systems have shown that delivered current is the critical determinant of success. 17 Devices charge to a programmable voltage, and the delivered current is inversely proportional to impedance by Ohm law. Both impedance and shock vector affect defibrillation efficacy in these studies. 16, 18 Thus, the present findings are consistent with these studies of other lead systems and support a general principal of defibrillation.
Limitations
There are several limitations of this study. First, it was a retrospective analysis, although as an Food and Drug Administration IDE study, there was close oversight of the quality of data. Chest radiographs were not available for failed shocks before system repositioning. S-ICD system position definitions and adjudications were performed based on available knowledge at that time and may be defined differently today. Although positioning parameters analyzed were believed to be the most important, assumptions should not be made about parameters not analyzed, such as PG depth or lateral positioning of the coil. HV impedances were not available for all patients. Finally, the studied cohort had less heart disease and comorbidities than more recent trials.
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Conclusions
S-ICD shock efficacy is associated with system position and HV system impedance. With device implantation in the recommended location, this rate could be improved. HV impedance is associated with inferior device implantation or inadequate coil depth and may be a reason for a lower rate of defibrillator success and should be avoided. High BMI predicted higher imped- ance and lower conversion success but not in those patients with appropriate positioning.
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